RXST: Entered a $60M+ collaboration with Alcon as product sales declined and leadership transitioned
RxSight, Inc. (RXST) reported flat revenue for Q2 2026, with collaboration revenue offsetting a decline in product sales, resulting in a net loss of $12.1M. The company secured a significant collaboration with Alcon, including a $60M upfront payment, potential milestones of $140M, and 30% …